1.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 80 Sponsor: Other Protocol IDs: FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 75 Sponsor: Other Protocol IDs: FRE-FNCLCC-GETUG-14/0207, EU-20503, NCT00104741
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0521, NCT00288080
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003-0819, NCT00388804
|
|
5.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0534, RTOG 0534, NCT00567580
|
|
6.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: NCI Protocol IDs: CAN-NCIC-PR12, PR12, NCT00651326
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: MUSC-031218, 100822, MUSC-HR-11357, NCT00103376
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: R04-0092, NCT00138918
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: over 21 Sponsor: Other Protocol IDs: 06-2040-A-02, L-8863, NCT00223665
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-07-C-0107, 07-C-0107, 7354, NCT00450463
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0621, RTOG 0621, NCT00528866
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UARIZ-04-0707-01, 04-0707-01, UARIZ-HSC04184, UARIZ-SRC17834, NCT00699907
|